Guanbo Wang | Medicine and Dentistry | Best Researcher Award

Dr. Guanbo Wang | Medicine and Dentistry | Best Researcher Award

Assistant Professor from The Dartmouth Institute for Health Policy and Clinical Practice, Dartmouth College, United States

Dr. Guanbo Wang is a distinguished postdoctoral research fellow at the CAUSALab, Harvard T.H. Chan School of Public Health. With a robust background in biostatistics and epidemiology, his work primarily focuses on developing innovative statistical methodologies to enhance causal inference in public health research. Dr. Wang’s expertise lies in integrating complex data sources to derive meaningful insights into treatment effects, particularly in the context of randomized clinical trials and observational studies. His interdisciplinary approach combines rigorous statistical theory with practical applications, aiming to inform clinical decision-making and health policy. Throughout his academic and professional journey, Dr. Wang has demonstrated a commitment to advancing public health through methodological innovation and collaborative research.

Professional Profile

Education

Dr. Wang’s academic journey commenced with a Bachelor of Science degree from China Textile University in Shanghai, China, in 1999. He pursued further studies at Shanghai Jiao Tong University, earning a Master of Science in 2002 and a Ph.D. in 2005. His doctoral research laid the foundation for his future endeavors in biostatistics and epidemiology. In 2019, Dr. Wang expanded his academic horizons as a visiting scholar at Harvard University, engaging with leading experts in the field. He culminated his formal education with a Ph.D. in Biostatistics from McGill University in 2022, where he honed his skills in statistical modeling and causal inference. Dr. Wang’s comprehensive educational background equips him with the theoretical knowledge and practical expertise necessary for his contributions to public health research.

Professional Experience

Dr. Wang’s professional experience encompasses a blend of academic research and industry collaboration. From 2015 to 2022, he served as a research assistant at McGill University and the McGill University Health Centre Research Institute, contributing to various projects in biostatistics and epidemiology. His industry experience includes internships and consultancy roles at prominent organizations such as Biogen, Roche, Baker & McKenzie, FINEOS Co., Ltd., KPMG China, and AXA Insurance Group. These roles provided Dr. Wang with practical insights into the application of statistical methods in diverse settings, including pharmaceuticals, legal consulting, and insurance. In 2023, he collaborated with the Center for Biostatistics in AIDS Research (CBAR), further solidifying his expertise in clinical trial analysis. Dr. Wang’s multifaceted professional background reflects his adaptability and commitment to applying statistical methodologies to real-world challenges.

Research Interests

Dr. Wang’s research interests are centered on advancing causal inference methodologies to address complex questions in public health. He focuses on data integration techniques that allow for the extension of causal inferences across different populations and data sources. His work on treatment effect heterogeneity aims to identify subpopulations that may benefit differently from interventions, thereby informing personalized medicine approaches. Dr. Wang also explores innovative trial designs, including adaptive and Bayesian frameworks, to enhance the efficiency and ethical conduct of clinical studies. Additionally, he is interested in incorporating prior knowledge, such as expert opinions, into statistical models to improve their interpretability and relevance. His methodological contributions are applied across various disease areas, including cardiovascular diseases, cancer, infectious diseases, and mental health disorders.

Research Skills

Dr. Wang possesses a comprehensive skill set in statistical methodologies and data analysis. His expertise includes nonparametric and semiparametric statistics, machine learning, high-dimensional data analysis, survival analysis, and optimization techniques. He is proficient in handling complex data structures, such as time-dependent treatments and longitudinal outcomes, commonly encountered in clinical and observational studies. Dr. Wang is adept at utilizing programming languages like R, Python, and C++ for statistical computing and developing analytical tools. His experience spans various data sources, including randomized clinical trials, electronic health records, and administrative databases. This diverse skill set enables him to tackle intricate research questions and contribute to methodological advancements in public health.

Awards and Honors

Dr. Wang’s contributions to biostatistics and public health research have been recognized through numerous awards and honors. He received the Fonds de Recherche du Québec – Santé Doctoral Training Grant (2019-2022), acknowledging his potential in health research. In 2021, he was honored with the Centre de Recherches Mathématiques StatLab Graduate Award and the McGill GREAT Award, reflecting his academic excellence. His achievements also include the McGill Graduate Excellence Award (2016-2021), the McGill Mobility Award (2019), and the McGill University Health Centre Studentship Fellowship (2019). Additionally, he was awarded the Statistical Society of Canada Biostatistics Travel Award in 2018. These accolades underscore Dr. Wang’s dedication to advancing statistical methodologies and their application in public health.

Conclusion

Dr. Guanbo Wang exemplifies a commitment to enhancing public health through methodological innovation in biostatistics and epidemiology. His extensive education and diverse professional experiences have equipped him with a robust foundation to address complex health research questions. Dr. Wang’s research endeavors aim to refine causal inference techniques, improve clinical trial designs, and integrate diverse data sources for comprehensive analyses. His contributions have the potential to inform evidence-based decision-making and personalized healthcare strategies. As he continues his work at the CAUSALab, Dr. Wang remains at the forefront of developing statistical methodologies that bridge the gap between data and impactful public health interventions.

Publications Top Notes

  1. Causal inference with multiple concurrent medications: A comparison of methods and an application in multidrug-resistant tuberculosis
    Authors: A.A. Siddique, M.E. Schnitzer, A. Bahamyirou, G. Wang, T.H. Holtz, G.B. Migliori, et al.
    Journal: Statistical Methods in Medical Research, 28(12), 3534–3549
    Year: 2019
    Citations: 31

  1. Estimating treatment importance in multidrug-resistant tuberculosis using Targeted Learning: An observational individual patient data network meta-analysis
    Authors: G. Wang, M.E. Schnitzer, D. Menzies, P. Viiklepp, T.H. Holtz, A. Benedetti
    Journal: Biometrics, 76(3), 1007–1016
    Year: 2020
    Citations: 17

  2. Using Effect Scores to Characterize Heterogeneity of Treatment Effects
    Authors: G. Wang, P.J. Heagerty, I.J. Dahabreh
    Journal: Journal of the American Medical Association
    Year: 2024
    Citations: 16

  1. Modeling treatment effect modification in multidrug-resistant tuberculosis in an individual patient data meta-analysis
    Authors: Y. Liu, M.E. Schnitzer, G. Wang, E. Kennedy, P. Viiklepp, M.H. Vargas, et al.
    Journal: Statistical Methods in Medical Research, 31(4), 689–705
    Year: 2022
    Citations: 10

  2. Evaluating hybrid controls methodology in early-phase oncology trials: A simulation study based on the MORPHEUS-UC trial
    Authors: G. Wang, M.P. Costello, H. Pang, J. Zhu, H.J. Helms, I. Reyes-Rivera, R.W. Platt, et al.
    Journal: Pharmaceutical Statistics, 23(1), 31–45
    Year: 2023
    Citations: 8

  3. Predictive factors of detectable viral load in HIV-infected patients
    Authors: A. Bouchard, F. Bourdeau, J. Roger, V.T. Taillefer, N.L. Sheehan, M. Schnitzer, G. Wang, et al.
    Journal: AIDS Research and Human Retroviruses, 38(7), 552–560
    Year: 2022
    Citations: 8

  4. Penalized G-estimation for effect modifier selection in the structural nested mean models for repeated outcomes
    Authors: A. Jaman, G. Wang, A. Ertefaie, M. Bally, R. Lévesque, R. Platt, M. Schnitzer
    Journal: Biometrics, 81(1)
    Year: 2024
    Citations: 5

  5. Robust integration of external control data in randomized trials
    Authors: G. Wang, R. Karlsson, J.H. Krijthe, I.J. Dahabreh
    Journal: arXiv preprint, arXiv:2406.17971
    Year: 2024
    Citations: 4

  1. Association between Sitting Time and Urinary Incontinence in the US Population: Data from the National Health and Nutrition Examination Survey (NHANES) 2007 to 2018
    Authors: D. Xingpeng, Y. Chi, X. Liyuan, W. Guanbo, L. Banghua
    Journal: Heliyon, 10(6)
    Year: 2024
    Citations: 4

  1. Integrating complex selection rules into the latent overlapping group Lasso for constructing coherent prediction models
    Authors: G. Wang, S. Perreault, R.W. Platt, R. Wang, M. Dorais, M.E. Schnitzer
    Journal: Statistics in Medicine
    Year: 2025
    Citations: 3

 

Carmine Siniscalchi | Medicine and Dentistry | Best Researcher Award

Dr. Carmine Siniscalchi | Medicine and Dentistry | Best Researcher Award

Medical Director from University of Parma, Italy

Dr. Carmine Siniscalchi is a distinguished medical researcher and physician specializing in internal medicine and cardiovascular diagnostics. With a career rooted in both academic excellence and clinical practice, he has demonstrated a strong commitment to advancing patient care through evidence-based research. Dr. Siniscalchi has authored 87 peer-reviewed publications indexed in Scopus, accumulating 722 citations and an h-index of 13—clear indicators of his research impact in the medical community. His expertise spans multiple domains including non-invasive cardiovascular imaging, thromboembolic disease, geriatric care, and the clinical implications of infectious diseases such as COVID-19. In addition to his research work, he has played a vital academic role as a contract professor and thesis advisor at the University of Parma. Through national and international collaborations, Dr. Siniscalchi has contributed to multidisciplinary studies that bridge clinical diagnostics with population health. His ability to integrate bedside ultrasonography, statistical methodologies, and epidemiological insights into routine practice underscores his innovative and patient-centered approach. With continued scholarly engagement and a forward-thinking mindset, he is well-positioned to make enduring contributions to medical science and education.

Professional Profile

Education

Dr. Carmine Siniscalchi’s academic background is marked by distinction and progressive specialization in the medical sciences. He earned his Medical Degree (Laurea Magistrale in Medicina e Chirurgia) with a score of 110/110 cum laude and special mention from the University of Campania Luigi Vanvitelli in 2009. Following this, he completed his specialization in Internal Medicine at the University of Parma in 2015, again achieving the highest marks with honors. He further pursued a Doctorate (Ph.D.) in Medical Sciences at the Department of Medicine and Surgery, University of Parma, which he completed with distinction in 2017. His doctoral research focused on the comparative efficacy of stress scintigraphy and contrast stress echocardiography in predicting cardiac events. To enhance his methodological expertise, he obtained a Second-Level Master’s Degree in Epidemiology and Biostatistics for Clinical Research from the University of Milano-Bicocca in 2021. This multidisciplinary academic progression has provided him with a strong foundation in both clinical practice and research methodology. Additionally, his classical high school education at Liceo Classico A. Rosmini of Palma Campania enriched his analytical and linguistic abilities, further supporting his academic career.

Professional Experience

Dr. Carmine Siniscalchi has built a multifaceted professional career combining clinical practice, academic teaching, and collaborative research. Since May 2022, he has served as a Contract Professor in Internal Medicine at the University of Parma’s School of Specialization in Cardiovascular Diseases. In this role, he actively contributes to the training of future medical specialists and supervises graduate and postgraduate thesis projects. His professional experience also includes participation in numerous interdisciplinary research projects at both national and international levels, with a strong focus on cardiovascular imaging and diagnostic techniques. Dr. Siniscalchi has held various roles in hospital settings, particularly focusing on internal medicine and geriatric care. His clinical work is deeply informed by his academic pursuits, allowing him to apply advanced diagnostics such as stress echocardiography and bedside ultrasonography in everyday practice. His capacity to balance medical education, clinical responsibility, and active research highlights his comprehensive professional competence. He is also noted for fostering international collaborations, contributing to peer-reviewed publications, and engaging in evidence-based improvements in patient care, particularly for complex cases involving multimorbidity and frailty in elderly populations.

Research Interests

Dr. Carmine Siniscalchi’s research interests are rooted in clinical relevance, focusing on improving diagnostic accuracy and therapeutic strategies in internal medicine. One of his primary interests lies in non-invasive cardiovascular diagnostics, particularly stress echocardiography and scintigraphy, for risk stratification in coronary artery disease. He has also explored the use of bedside ultrasonography as a decision-making tool in hospital settings. His work extends to thromboembolic diseases, both acute and chronic, with emphasis on diagnosis, treatment, and patient outcomes. In recent years, he has actively investigated cardiovascular risk assessment during pregnancy, contributing to studies on maternal cardiac adaptation. A significant portion of his research is also devoted to geriatrics, including the clinical management of frail and multimorbid elderly patients and the impact of hospital-acquired infections, including COVID-19, in this vulnerable population. His background in epidemiology and biostatistics enables him to design and interpret studies that integrate clinical practice with public health implications. Through interdisciplinary collaboration, Dr. Siniscalchi seeks to bridge gaps between imaging technology, clinical decision-making, and long-term patient outcomes. His goal is to foster research that directly improves diagnostic pathways and therapeutic efficacy across diverse patient populations.

Research Skills

Dr. Siniscalchi possesses a robust and diverse set of research skills that align with his multidisciplinary academic and clinical profile. He is adept in epidemiological research design, biostatistics, and data interpretation, all enhanced by his advanced training in epidemiology from the University of Milano-Bicocca. His expertise in cardiovascular imaging, including stress echocardiography, pulse-cancellation echocardiography, and computed tomography, enables him to lead and contribute to high-impact diagnostic studies. He is skilled in conducting bedside ultrasonographic assessments, which he utilizes both as a clinical tool and a subject of investigation. His experience with manuscript writing, peer-reviewed publishing, and academic mentoring reflects his strong academic communication skills. Additionally, he has effectively managed collaborative research projects, integrating input from multi-center teams. His familiarity with scientific databases such as PubMed, Scopus, and Web of Science allows for rigorous literature review and citation analysis. Furthermore, Dr. Siniscalchi has shown proficiency in mentorship, having supervised multiple medical and specialty theses. His ability to bridge clinical insight with methodological precision makes him a valuable contributor to translational medical research.

Awards and Honors

Dr. Carmine Siniscalchi has been consistently recognized for his academic excellence and research acumen throughout his career. He graduated with honors in both his undergraduate and postgraduate medical education, earning a Laurea Magistrale cum laude with special mention and completing his Specialization in Internal Medicine and Ph.D. in Medical Sciences with top honors. While formal awards such as named prizes or competitive grants are not detailed in the available profile, the quality of his academic achievements and consistent recognition by examination commissions reflect a strong professional standing. His invitation to serve as a Contract Professor and his repeated role as thesis advisor indicate trust in his expertise and mentorship within the academic community. His publications in high-impact journals and collaborations with leading researchers further underscore his professional credibility. Being positioned as first, second, or corresponding author in key studies also highlights his leadership in research initiatives. As his career continues to evolve, more formal honors such as awards from scientific societies or recognition at international conferences are likely to follow, given his current trajectory and consistent scholarly output.

Conclusion

Dr. Carmine Siniscalchi exemplifies the qualities of an accomplished medical researcher and educator, with a strong foundation in clinical practice and a deep commitment to advancing diagnostic methodologies and patient care. His academic credentials, professional appointments, and impactful research contributions—particularly in cardiovascular diagnostics and internal medicine—make him a compelling candidate for recognition such as the Best Researcher Award. Through active involvement in teaching, publication, and collaborative research, he has demonstrated a balance of scholarly rigor and clinical pragmatism. While there is scope for further recognition through competitive awards and international grants, Dr. Siniscalchi’s current record already reflects significant contributions to the field. His ability to mentor students, collaborate across institutions, and address critical healthcare issues—ranging from cardiovascular risk to aging populations—positions him as a leader in translational medical research. In summary, Dr. Siniscalchi not only meets the standards of research excellence but also brings a humanistic and evidence-driven perspective to medicine, making him a strong nominee for distinguished honors in his field.

Publications Top Notes

  1. Title: Low-Density Lipoprotein Cholesterol Levels and Bleeding Risk in Venous Thromboembolism
    Authors: Carmine Siniscalchi, Tiziana Meschi, Pierpaolo Di Micco, Joaquín Alfonso-Megido, Manuel Monreal
    Journal: JAMA Network Open
    Year: 2025

  2. Title: Venous Thromboembolism in Patients Aged ≥90 Years: Trends in Clinical Features, Treatment, and Outcomes—RIETE Registry
    Authors: Ludovic Lafaie, Géraldine Poénou, Olivier Hanon, Alberto Rivera-Gallego, Ana Rodríguez-Cobo
    Journal: Journal of the American Geriatrics Society
    Year: 2025
    Citations: 2

  3. Title: Predictors of Acute Myocardial Infarction: A Machine Learning Analysis After a 7-Year Follow-Up
    Authors: Marco Casciaro, Pierpaolo Di Micco, Alessandro Tonacci, Sebastiano Gangemi, E. Imbalzano
    Journal: Clinics and Practice
    Year: 2025

  4. Title: Integrated Lung, Diaphragm and Lower Limb Muscular Ultrasound: Clinical Correlations in Geriatric Patients with Acute Respiratory Illness
    Authors: Nicoletta Cerundolo, Carmine Siniscalchi, Chukwuma Okoye, Andrea Nouvenne, Andrea Ticinesi
    Journal: Diagnostics
    Year: 2025

  5. Title: Baseline Hemoglobin Values and Clinical Outcomes in Acute Venous Thromboembolism: Insights From the RIETE Registry
    Authors: Carmine Siniscalchi, Pierpaolo Di Micco, Antonella Tufano, Pablo Javier Marchena, Mar Martín del Pozo
    Year: 2025

  6. Title: The Prognostic Value of Clinical Frailty Scale in COVID-19 Pneumonia Across Different Pandemic Phases: A Comparison Between the First and the Fourth Wave
    Authors: Carmine Siniscalchi, Andrea Ticinesi, Angela Guerra, Emanuela Porro, Tiziana Meschi
    Journal: Frontiers in Medicine
    Year: 2025

  7. Title: Proprotein Convertase Subtilisin/Kexin Type 9: A Promising Marker of Cardiovascular Risk in Post-Menopausal Diabetic Women in Primary Prevention
    Authors: Michelangelo Rottura, Maria Antonietta Barbieri, Carmine Siniscalchi, Natasha Irrera, E. Imbalzano
    Journal: Frontiers in Medicine
    Year: 2025

  8. Title: Gut Microbiome and Bone Health: Update on Mechanisms, Clinical Correlations, and Possible Treatment Strategies
    Authors: Andrea Ticinesi, Carmine Siniscalchi, Tiziana Meschi, A. Nouvenne
    Year: 2025
    Citations: 1

  9. Title: Antithrombotic Treatment in Antiphospholipid Syndrome: A Review
    Authors: Carmine Siniscalchi, Francesca Futura Bernardi, Pierpaolo Di Micco, Tiziana Meschi, Ugo Trama
    Year: 2025

 

shibba takkar chhabra | Medicine | Best Researcher Award

Prof. Shibba Takkar Chabra | Medicine | Best Researcher Award

Prof.shibba takkar chhabra, Dayanand Medical College & Hospital, India

Prof. Shibba Takkar Chhabra is a leading cardiologist at Dayanand Medical College & Hospital in India, with an impressive educational background including an MBBS, MD, and DM in Cardiology. She has dedicated her career to improving cardiac care for women and has been a pivotal figure in organizing national conferences to raise awareness about women’s heart health. As the chief editor of several medical publications and an active member of various cardiology societies, Prof. Chhabra is committed to advancing research and education in the field of cardiology.

Profile

Scopus Profile